Viewing Study NCT01091051


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-01-05 @ 5:45 PM
Study NCT ID: NCT01091051
Status: TERMINATED
Last Update Posted: 2013-06-11
First Post: 2010-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis
Sponsor: Innovaderm Research Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Palmo-Plantar Pustular Psoriasis View
None Palmo-Plantar Pustulosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ustekinumab, Palmo-Plantar, Pustular Psoriasis, Pustulosis View